Lisi, Lucia
 Distribuzione geografica
Continente #
EU - Europa 3.112
NA - Nord America 2.693
AS - Asia 354
SA - Sud America 6
AF - Africa 3
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.171
Nazione #
US - Stati Uniti d'America 2.670
PL - Polonia 1.233
DE - Germania 688
IT - Italia 368
SE - Svezia 308
CN - Cina 222
UA - Ucraina 172
GB - Regno Unito 94
IE - Irlanda 88
FR - Francia 77
IN - India 68
FI - Finlandia 38
VN - Vietnam 18
CA - Canada 17
BE - Belgio 15
TR - Turchia 15
ES - Italia 7
JP - Giappone 7
NL - Olanda 7
HK - Hong Kong 6
MX - Messico 6
RU - Federazione Russa 5
CH - Svizzera 4
CL - Cile 4
IR - Iran 4
SG - Singapore 4
CZ - Repubblica Ceca 2
HU - Ungheria 2
IQ - Iraq 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AL - Albania 1
AR - Argentina 1
AU - Australia 1
BD - Bangladesh 1
BG - Bulgaria 1
BR - Brasile 1
CI - Costa d'Avorio 1
EG - Egitto 1
GR - Grecia 1
ID - Indonesia 1
IL - Israele 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
RO - Romania 1
SA - Arabia Saudita 1
TH - Thailandia 1
TN - Tunisia 1
Totale 6.171
Città #
Warsaw 1.218
Chandler 441
Fairfield 245
Ashburn 236
Jacksonville 135
Houston 133
Wilmington 131
Woodbridge 129
San Mateo 107
Cattolica 98
Seattle 92
Dublin 88
Verona 84
Ann Arbor 82
Cambridge 82
Nanjing 63
Dearborn 49
Bremen 46
New York 46
Milan 40
Redwood City 40
Munich 37
Nürnberg 36
Lawrence 33
Nanchang 31
Boston 30
Rome 25
Beijing 23
Princeton 21
Lancaster 20
Chicago 17
Dong Ket 17
Brussels 15
Marseille 15
Mountain View 15
Kraków 14
Pune 14
Redmond 14
Hangzhou 13
San Diego 13
University Park 13
Phoenix 12
Izmir 11
Norwalk 11
Shanghai 11
Shenyang 11
Changsha 10
Fremont 10
Jiaxing 10
Leawood 10
London 10
Boardman 9
Zhengzhou 9
Hebei 8
Toronto 8
Andover 6
Falls Church 6
Guangzhou 6
Monmouth Junction 6
Nanning 6
Corchiano 5
Gurgaon 5
Kunming 5
Paris 5
Philadelphia 5
Busto Arsizio 4
Chiswick 4
Fondi 4
Hefei 4
Hong Kong 4
Jinan 4
Trento 4
Augusta 3
Detroit 3
Florence 3
Frankfurt am Main 3
Gustavo Adolfo Madero 3
Halifax 3
Los Angeles 3
Manchester 3
Orwell 3
Tianjin 3
Viterbo 3
Zurich 3
Addison 2
Akhisar 2
Anzio 2
Bogen 2
Brooklyn 2
Broomfield 2
Budapest 2
Cankaya 2
Cupertino 2
El Paraiso 2
Falkenstein 2
Indiana 2
Madrid 2
Novokuznetsk 2
Rimini 2
Romainville 2
Totale 4.292
Nome #
The mTOR kinase inhibitors polarize glioma-activated microglia to express a M1 phenotype 348
mTOR kinase: a possible pharmacological target in the management of chronic pain 346
Monocytes from depressed patients display an altered pattern of response to endotoxin challenge 345
Novel sensitive, specific and rapid pharmacogenomic test for the prediction of abacavir hypersensitivity reaction: HLA-B*57:01 detection by real-time PCR 314
The mTOR kinase inhibitor rapamycin decreases iNOS mRNA stability in astrocytes 301
Proinflammatory-activated trigeminal satellite cells promote neuronal sensitization: relevance for migraine pathology 301
Expression of iNOS, CD163 and ARG-1 taken as M1 and M2 markers of microglial polarization in human glioblastoma and the surrounding normal parenchyma 292
The anti-inflammatory effects of dimethyl fumarate in astrocytes involve glutathione and haem oxygenase-1 275
Neuronal Conditional Knockout of Collapsin Response Mediator Protein 2 Ameliorates Disease Severity in a Mouse Model of Multiple Sclerosis 155
Transcriptome analysis of alcohol-treated microglia reveals downregulation of beta amyloid phagocytosis 136
Cortistatin modulates the expression and release of corticotrophin releasing hormone in rat brain. Comparison with somatostatin and octreotide. 129
Antiretrovirals inhibit arginase in human microglia 123
Trigeminal satellite cells express functional calcitonin gene-related peptide receptors, whose activation enhances interleukin-1β pro-inflammatory effects. 122
Variability of raltegravir plasma levels in the clinical setting 117
Phospho-mTOR expression in human glioblastoma microglia-macrophage cells 113
Trigeminal satellite cells express functional calcitonin gene-related peptide receptors, whose activation enhances interleukin-1β pro-inflammatory effects 104
Validation of an UPLC-MS/MS Method for Quantitative Analysis of Raltegravir in Human Plasma Samples 102
Pro-inflammatory activation of a new immortalized human microglia cell line 101
The activation of type 1 corticotropin releasing factor receptor (CRF-R1) inhibits proliferation and promotes differentiation of neuroblastoma cells in vitro via p27Kip1 protein up-regulation and c-Myc mRNA down-regulation 95
Modulatory effects of the CCR5 antagonist maraviroc on microglial pro-inflammatory activation elicited by gp120 94
Effects of olanzapine and quetiapine on corticotropin-releasing hormone release in the rat brain. 94
Proinflammatory-activated glioma cells induce a switch in microglial polarization and activation status, from a predominant M2b phenotype to a mixture of M1 and M2a/B polarized cells 90
Antiretrovirals inhibit arginase in human microglia 89
Antiretroviral agents increase NO production in gp120/IFNγ-stimulated cultures of rat microglia via an arginase-dependent mechanism 88
Tapentadol inhibits calcitonin gene-related peptide release from rat brainstem in vitro 86
Detection of HLA-B*57:01 by real-time PCR: implementation into routine clinical practice and additional validation data 86
Rapamycin reduces clinical signs and neuropathic pain in a chronic model of experimental autoimmune encephalomyelitis 83
Endocrine disruptors and human corpus luteum: in vitro effects of phenols on luteal cells function. 80
Involvement of mTOR kinase in cytokine-dependent microglial activation and cell proliferation 78
Switch to maraviroc with darunavir/r, both QD, in patients with suppressed HIV-1 was well tolerated but virologically inferior to standard antiretroviral therapy: 48-Week results of a randomized trial 76
Pro-inflammatory-activated glioma cells induce a switch in microglial polarization and activation status, from a predominant M2b phenotype to a mixture of M1 and M2a/b polarized cells 75
Exploiting microglial functions for the treatment of glioblastoma 75
Endocrine disruptors and human reproductive failure: the in vitro effect of phthalates on human luteal cells 72
Clinical experience with CTLA-4 blockade for cancer immunotherapy: From the monospecific monoclonal antibody ipilimumab to probodies and bispecific molecules targeting the tumor microenvironment 72
Diverging effects of cortistatin and somatostatin on the production and release of prostanoids from rat cortical microglia and astrocytes 71
mTOR kinase, a key player in the regulation of glial functions: Relevance for the therapy of multiple sclerosis 70
Pdia3 expression in glioblastoma modulates macrophage/microglia pro-tumor activation 70
Pharmacokinetics of high-dose tigecycline in critically ill patients with severe infections 70
Blockade of CCR5 receptor prevents M2 microglia phenotype in a microglia-glioma paradigm 67
Exploiting Microglial Functions for the Treatment of Glioblastoma 66
Vascular endothelial growth factor receptor 1 in glioblastoma-associated microglia/macrophages 64
The in vitro rabbit whole bladder as a model to investigate the urothelial transport of anticancer agents The ONCOFID-P paradigm. 63
Influence of the Oral Dissolution Time on the Absorption Rate of Locally Administered Solid Formulations for Oromucosal Use: The Flurbiprofen Lozenges Paradigm 63
Interactions between Integrase Inhibitors and human Arginase 1 61
The anti-vascular endothelial growth factor receptor-1 monoclonal antibody D16F7 inhibits invasiveness of human glioblastoma and glioblastoma stem cells 61
Multiple direct and indirect mechanisms drive estrogen-induced tumor growth in high grade serous ovarian cancers 57
The novel HSP90 inhibitor, PU-H71, suppresses glial cell activation but weakly affects clinical signs of EAE 55
The free fractions of circulating docosahexaenoic acid and eicosapentenoic acid as optimal end-point of measure in bioavailability studies on n-3 fatty acids 55
Approaching coronavirus disease 2019: Mechanisms of action of repurposed drugs with potential activity against SARS-CoV-2 55
DNA inhibitors for the treatment of brain tumors 54
Development of an uplc-ms/ms method for quantitative analysis of clotrimazole in human plasma samples 48
Pharmacokinetics of high-dose tigecycline in critically ill patients with severe infections 47
The effects of CHF6467, a new mutated form of NGF, on cell models of human glioblastoma. A comparison with wild-type NGF 45
Tigecycline pharmacokinetics in critically ill patients on renal replacement therapy: possible warnings and potential perspectives for the research agenda 38
mTOR Inhibition Is Effective against Growth, Survival and Migration, but Not against Microglia Activation in Preclinical Glioma Models 17
The effects of painless nerve growth factor on human microglia polarization 15
Use of High-Dose Nebulized Colistimethate in Patients with Colistin-Only Susceptible Acinetobacter baumannii VAP: Clinical, Pharmacokinetic and Microbiome Features 11
A Vicious NGF-p75NTR Positive Feedback Loop Exacerbates the Toxic Effects of Oxidative Damage in the Human Retinal Epithelial Cell Line ARPE-19 2
Totale 6.282
Categoria #
all - tutte 18.225
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.225


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019216 0 0 0 0 0 0 0 0 0 61 94 61
2019/20201.259 118 71 142 188 66 90 105 51 142 59 158 69
2020/2021907 58 100 25 74 115 64 147 20 105 65 97 37
2021/2022755 74 56 13 29 66 30 11 97 30 60 170 119
2022/20231.127 128 163 107 188 76 137 25 95 137 20 27 24
2023/2024468 35 146 27 53 27 68 65 33 9 5 0 0
Totale 6.282